Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 374-376

  García Arata, M Isabel ^a   Baquero, Fernando ^a   De Rafael, Luis ^a   De Argila, Carlos Martín ^a   Gisbert, Javier P ^a   Bermejo, Fernando ^a   Boixeda, Daniel ^a   Cantón, Rafael ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CLARITHROMYCIN; ERYTHROMYCIN; GUANINE; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; GENE; GENE MUTATION; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0345320399     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.374     Document Type: Article

References (21)

1. Blaser, M. J. 1997. Medical significance of H. pylori. In C. L. Clayton and H. L. T. Mobley (ed.), Helicobacter pylori protocols. Humana Press, New York, N.Y.
2. Debets-Ossenkopp, Y. J., A. B. Brinkman, E. J. Kuipers, J. G. Kusters, and C. M. J. E. Vandenbroucke-Grauls. 1997. Explaining the preferential A to G mutation in clarithromycin resistance in Helicobacter pylori, abstr. C-69. In Program and abstracts of the 37th International Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. European Helicobacter pylori Study Group. 1997. Current European concepts in the management of Helicobacter pylori infection. Gut 41:8-13.
4. Glupczynski, Y. 1992. European multicentre study group on antibiotic susceptibility of Helicobacter pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 11:777-781.
5. Glupczynski, Y., M. Labbé, W. Hansen, F. Crokaert, and E. Yourassowsky. 1991. Evaluation of the E-test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J. Clin. Microbiol. 29:2072-2075.
6. Graham, D. Y., W. A. de Boer, and G. N. J. Tytgat. 1996 Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am. J. Gastroenterol. 91:1072-1076.
7. Hsieh, P. F., J. C. Yang, J. T. Lin, and J. T. Wang. 1998. Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. J. Formos. Med. Assoc. 97:445-452.
8. Hultén, K., A. Gibreel, O. Sköld, and L. Engstrand. 1997. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob. Agents Chemother. 41:2550-2553.
9. Markham, A., and D. McTavish. 1996. Clarithromycin and omeprazole as Helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders. Drugs 51:161-178.
10. Neu, H. C. 1991. The development of macrolides: clarithromycin in perspective. J. Antimicrob. Chemother. 27(Suppl. A):1-9.
11. Occhialini, A., M. Urdaci, F. Doucet-Populaire, C. M. Bébéar, H. Lamouliatte, and F. Mégraud. 1997. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes, Antimicrob. Agents Chemother. 41:2724-2728.
12. Stone, G. G., D. Shortridge, R. K. Flamm, J. Versalovic, J. Beyer, K. Idler, L. Zulawinski, and S. K. Tanaka. 1996. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1:227-228.
13. Stone, G. G., D. Shortridge, J. Versalovic, J. Beyer, R. K. Flamm, D. Y. Graham, A. T. Ghoneim, and S. K. Tanaka. 1997. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob. Agents Chemother. 41:712-714.
14. Szczebara, F., L. Dhaenens, P. Vincent, and M. O. Husson. 1997. Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 16:162-164.
15. Taylor, D. E., Z. Ge, D. Purych, T. Lo, and K. Hiratsuka. 1997. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents Chemother. 41:2621-2628.
16. Tomb, J.-F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Rickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547.
17. Versalovic, J., D. Shortridge, K. Kibler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Y. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480.
18. Versalovic, J., M. S. Osato, K. Spakovsky, M. P. Dore, R. Reddy, G. G. Stone, D. Shortridge, R. K. Flamm, S. K. Tanaka, and D. Y. Graham. 1997. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J. Antimicrob. Chemother. 40: 283-286.
19. Wang, G., and D. E. Taylor. 1998. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob. Agents Chemother. 42:1952-1958.
20. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585.
21. Xia, H.-X., M. Buckley, C. T. Keane, and C. A. O'Morain. 1997. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. J. Antimicrob. Chemother. 40:283-286.